Baricitinib is used to treat arthritis, both alone and in combination with methotrexate. The compound is a reversible inhibitor of Janus kinase enzymes. Baricinitib was approved for use in the EU in 2017, but the USFDA has refused to approve the drug, citing concerns over safety and dosage.
| px | px | dpi | = | cm | x | cm | = | MB |
Details
Creative#:
TOP22812612
Source:
達志影像
Authorization Type:
RM
Release Information:
須由TPG 完整授權
Model Release:
N/A
Property Release:
N/A
Right to Privacy:
No
Same folder images:
Loading